Economic value of declining mortality in under five children in Rwanda, 2000 - 2023. Global Burden of Disease estimates Analysis

Every year, millions of children around the world face a race against time before their fifth birthday. In the field of public health, researchers track how many of these children survive and how many fall ill, not just to count lives, but to understand the health of a nation. A key concept in this work is the "disability-adjusted life year," a way of measuring the total burden of disease by combining the years of life lost to early death with the years lived in poor health. When a country manages to keep more children alive and healthy, it does not just save lives; it saves a tremendous amount of future potential and economic value. This value is often hidden, buried in statistics that show a decline in deaths but fail to translate that success into the language of budgets and investment. Understanding the true worth of these saved lives helps governments decide where to spend their limited money to get the biggest return for their people.

In a new analysis, Jean Marie Vianney Niyonsenga, a researcher based in Kigali, has put a price tag on Rwanda's remarkable journey in child survival. Since the year 2000, Rwanda has achieved one of the fastest drops in child mortality in history, moving from a time of devastation to a model of recovery. Niyonsenga used global health data to trace this path from 2000 to 2023, looking at how many children died, how many years of healthy life were lost, and what specific diseases caused the most harm. The goal was to move beyond simple counts and answer a difficult question: what is the economic value of the children who are now alive because Rwanda's health system improved? By applying a specific method that measures the cost of saving a year of healthy life within Rwanda's own economy, the study reveals that the country's progress is worth billions of dollars every year, a sum that dwarfs the cost of the health programs that made it possible.

The numbers tell a story of dramatic change. In the year 2000, Rwanda saw approximately 55,800 children under five die. By 2023, that number had fallen to about 19,100. This represents a drop of nearly two-thirds in the number of deaths. When the researcher calculated how many lives were saved by this improvement, the total came to nearly 700,000 children who would have died if the conditions of the year 2000 had persisted. This is not just a statistic; it represents hundreds of thousands of families who did not have to endure the loss of a child. The study also looked at the "burden" of disease, which includes both death and the years children spent sick or disabled. This burden dropped by nearly 65 percent over the same period. The researcher estimated that the value of this reduction, calculated using Rwanda's own economic benchmarks, amounts to roughly 1.7 billion US dollars every year. To put this in perspective, this annual value of saved lives is nearly twice as large as the total economic burden that remains from the children who are still sick or dying today.

However, the story is not just about how much has been won, but also about where the remaining challenges lie. The causes of child death have shifted significantly over the last two decades. In 2000, the biggest killers were infectious diseases like malaria, pneumonia, and diarrhea, along with measles and HIV. These diseases have been brought under control through vaccines, better medicine, and community health workers. Today, while these infections are still present, the leading cause of death has changed. The biggest threat to Rwandan children now comes from the neonatal period, meaning the first month of life. Conditions related to birth, such as complications during delivery or premature birth, now account for more than a third of all under-five deaths. This shift suggests that the health system has become very good at fighting infections but now faces a harder challenge: keeping the most fragile newborns alive.

Another major finding concerns the root causes of illness. The study identified that child and maternal malnutrition is the single biggest factor driving disease and death among young children in Rwanda. It is responsible for more than 40 percent of the total burden of illness in this age group. When the researcher calculated the economic cost of this malnutrition, it came to about 383 million US dollars per year. This figure is significant because it is higher than the amount of money the government currently sets aside specifically for nutrition programs. This gap suggests that while the country has made progress in reducing malnutrition, the economic case for investing even more in this area is very strong. The study also found that air pollution and unsafe water remain important contributors to the problem, but malnutrition stands out as the most urgent target for investment.

The analysis also places Rwanda's success in a broader context. The country has improved its health outcomes faster than almost any other nation since 2000, yet the study notes that Rwanda's overall health performance is now roughly equal to what would be expected for a country with its level of economic development. It has not yet surpassed its peers, but it has caught up to them. This is an important distinction. It means that the country is not just maintaining a lead; it is still in the process of closing a gap. The researchers suggest that the narrative of Rwanda as a miraculous outlier should be tempered with the reality that there is still work to be done to reach the level of health seen in similar nations. The gains made so far are real and massive, but the potential for further improvement remains.

Ultimately, this paper provides a clear economic argument for continuing to invest in child health, particularly in the areas of newborn care and nutrition. The value of the lives saved since 2000 is so large that it justifies the costs of the health programs that achieved it. The study shows that the remaining burden of disease is concentrated in a few specific areas, making it possible for policymakers to target their resources effectively. By focusing on the needs of newborns and addressing malnutrition, Rwanda can continue to build on its success. The research does not claim to have solved the problem, but it offers a precise map of where the problems remain and proves that the cost of inaction is far higher than the cost of continued investment. The path forward is clear: the economic value of saving a child's life is immense, and the tools to do so are within reach.